| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
PAOPA manufacturers
- PAOPA
-
- $1180.00
-
2026-07-27
- CAS:114200-31-6
- Purity: 100.00%
- Supply Ability: 10g
|
| Product Name: | PAOPA | | Synonyms: | PAOPA;(3R)-2-Oxo-3-[[(2S)-2-Pyrrolidinylcarbonyl]amino]-1-pyrrolidineacetamide;PAOPA (S)-N-((R)-1-(2-amino-2-oxoethyl)-2-oxopyrrolidin-3-yl)pyrrolidine-2-carboxamide;1-Pyrrolidineacetamide, 2-oxo-3-[[(2S)-2-pyrrolidinylcarbonyl]amino]-, (3R)- | | CAS: | 114200-31-6 | | MF: | C11H18N4O3 | | MW: | 254.29 | | EINECS: | | | Product Categories: | | | Mol File: | 114200-31-6.mol |  |
| | PAOPA Chemical Properties |
| Boiling point | 647.6±55.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble to 100 mM in water and to 100 mM in DMSO | | form | Powder | | pka | 14.21±0.20(Predicted) | | color | White to off-white |
| | PAOPA Usage And Synthesis |
| Uses | PAOPA is an allosteric modulator and a potent dopamine D2 receptor. It is used to treat psychiatric illnesses, such as schizophrenia. | | Definition | ChEBI: (2S)-N-[(3R)-1-(2-amino-2-oxoethyl)-2-oxo-3-pyrrolidinyl]-2-pyrrolidinecarboxamide is a peptide. | | in vivo | Chronic administration of PAOPA (1 mg/kg; ip; once a day for 45 days) causes an increase in the expression of D2 receptor regulators and downstream molecules (including GRK2, arrestin-3, and extracellular receptor kinase ERK 1/2) in mice[1]. | | IC 50 | D2 Receptor |
| | PAOPA Preparation Products And Raw materials |
|